Cardiovascular effects of relaxin-2: therapeutic potential and future perspectives

N Almeida-Pinto, TB Dschietzig, C Brás-Silva… - Clinical Research in …, 2024 - Springer
The hormone relaxin-2 has emerged as a promising player in regulating the physiology of
the cardiovascular system. Through binding to the relaxin family peptide receptor 1 (RXFP1) …

The role of relaxin in anterior cruciate ligament injuries: a systematic review

GK Berger, ZA Rockov, C Byrne… - European Journal of …, 2023 - Springer
Objective Anterior cruciate ligament (ACL) tears are exceedingly common among the
athletic population and are seen with higher incidence in females. Observational studies …

Novel biological therapies targeting heart failure: myocardial rejuvenation

AJ Favreau-Lessard, S Ryzhov… - Heart failure …, 2016 - heartfailure.theclinics.com
Cardiovascular disease (CVD) is the leading cause of death across the globe, accounting
for 17.3 million deaths per year. 1 In the United States, more than 1 in 3 adults suffers from …

[PDF][PDF] HEART FAILURE CLINICS

J NARULA, E BOSSONE - 123library.org
By analyzing the patterns, causes and effects of coronary artery disease (CAD) in different
populations, the field of epidemiology has helped identify risk factors for CAD and directs …

Etude de la réponse des lymphocytes T spécifiques de l'hormone humaine H2-relaxine et de modifications non-naturelles: perspectives pour la réduction de l' …

A Azam - 2018 - theses.hal.science
Ce projet a accompagné le développement pré-clinique de l'hormone humaine Relaxine-2
(Rln2) ayant induit des anticorps durant des essais cliniques, il est axée autour de 2 …